The Business Times
business-time-50

Temasek leads US$85m investment round for gene therapy startup

google-preferred-sourceAdd BT as a preferred source
Published Tue, Feb 26, 2019 · 09:50 PM

Singapore

IMMUNE cell gene therapy startup Gracell Biotechnologies has raised US$85 million through a Series B round led by Singapore government investment firm Temasek Holdings.

Also taking part in the financing round were Lilly Asia Ventures, Kington Capital, King Star Capital and Chengdu Miaoji.

Temasek

TRENDING NOW

Yeoh Pei Xien is the youngest grandchild of Yeoh Tiong Lay, who founded Malaysian multinational conglomerate YTL Corporation.

Yeoh Pei Xien: YTL’s third-gen scion with a pastor’s heart

The hiring push comes as Singapore’s banks expand their wealth franchises across Asia.

Singapore banks’ battle for wealth talent goes beyond private bankers

The move comes as Indonesia seeks to strengthen its investment proposition and attract more foreign capital.

Indonesia offers sweeping tax breaks under new financial-centre law

Norris Road in Little India. An operator of unlicensed money remittance services for migrant workers was sentenced to jail recently.

A ‘shadow bank’ hiding in Singapore’s Little India casts light on financial services gap

Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
View More